Newer Anti-HIV Drugs Safest, Most Effective During Pregnancy
3-11-2020Cross-posted from NIAID NewsroomDolutegravir-containing regimen exhibited superior safety profile in large, NIH-supported study of pregnant women.The antiretrov…
National Institute of Allergy & Infectious Diseases
NIH Study Finds Lower Concentration of PrEP Drug in Pregnant Young Women
3-9-2020Cross-posted from NIAID NewsroomAmong African adolescent girls and young women who took HIV pre-exposure prophylaxis (PrEP) daily, levels of the PrEP drug tenof…
Superior AIDS-Kaposi’s Sarcoma Treatment Improves Outcomes in Resource-Limited Settings
3-9-2020Cross-posted from NIAID NewsroomThe cancer drug paclitaxel and a suppressive regimen of antiretroviral therapy (ART) is an effective treatment for AIDS-related …
Drug-Delivery Technology Leads to Sustained HIV Antibody Production in NIH Study
3-9-2020Cross-posted from NIAID NewsroomA new approach to direct the body to make a specific antibody against HIV led to sustained production of that antibody for more …
Watch Next Week: HIV Research Updates from CROI 2020
3-4-2020HIV.gov will bring you live interviews on the latest developments in HIV research from CROI next week with NIH’s Dr. Carl Dieffenbach.
NIH-Funded Clinical Trial to Test PrEP, Dapivirine Ring for Safety in Pregnant Women
2-13-2020Cross-posted from NIAID NewsroomThe first clinical trial specifically designed to test the safety of the monthly dapivirine vaginal ring in pregnant women has …
Experimental HIV Vaccine Regimen Ineffective in Preventing HIV
2-3-2020NIAID has stopped administration of investigational vaccinations in its HVTN 702 clinical trial taking place in South Africa.
NIAID Launches First Clinical Trial to Test Antibody–Drug Combination for Long-Acting HIV Treatment
1-22-2020Cross-posted from NIAID NewsroomThe first clinical trial to test the combination of a long-acting anti-HIV drug plus a powerful HIV antibody as a long-acting tr…
Efforts to End the HIV Epidemic Must Not Ignore People Already Living With HIV
12-16-2019
Video: NIH’s Dr. Dieffenbach Discusses How Implementation Research Is Supporting EHE Jurisdictions
11-20-2019NIH recently invested $11.3 million to find the most effective ways to diagnose, prevent, and treat HIV using highly effective methods that are already availabl…